Farah L. Rehman

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Supporting adherence to adjuvant CDK4/6 inhibitors in women with early breast cancer (SWEET-PLUS): protocol for a multicentre UK study using qualitative and co-development methods.

Supporting adherence to adjuvant CDK4/6 inhibitors in women with early breast cancer (SWEET-PLUS): protocol for a multicentre UK study using qualitative and co-development methods.

Journal: BMJ open

Published: August 11, 2026

Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-need.

Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-need.

Journal: The journal of liquid biopsy

Published: April 10, 2026

Supporting women with adherence to adjuvant endocrine therapy (SWEET): feasibility study of the HT&Me intervention.

Supporting women with adherence to adjuvant endocrine therapy (SWEET): feasibility study of the HT&Me intervention.

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society

Published: April 15, 2025

Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer.

Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer.

Journal: Trials

Published: September 13, 2024

Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer.

Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer.

Journal: JCO precision oncology

Published: May 01, 2024

Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells.

Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells.

Journal: Cancer discovery

Published: October 05, 2023

Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life.

Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life.

Journal: Breast (Edinburgh, Scotland)

Published: March 10, 2023

A novel approach to managing circumferential entrapment of a child's tongue within a plastic lid.

A novel approach to managing circumferential entrapment of a child's tongue within a plastic lid.

Journal: The Journal of laryngology and otology

Published: February 09, 2022

A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast Cancer.

A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast Cancer.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: May 17, 2021

Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients.

Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients.

Journal: Breast cancer research and treatment

Published: November 17, 2020

Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience.

Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience.

Journal: Breast cancer research and treatment

Published: January 07, 2019

Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence.

Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 08, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026